BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4831006)

  • 1. The behavior of isotope labelled blood proteins in thrombosis.
    Strachan CJ; Scully MF; Kakkar VV
    Thromb Res; 1974 Feb; 4(2):303-18. PubMed ID: 4831006
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic fate of urokinase.
    Tajima H; Ishiguro J; Nonaka R; Kurita M; Tanaka S
    Chem Pharm Bull (Tokyo); 1974 Apr; 22(4):727-35. PubMed ID: 4418203
    [No Abstract]   [Full Text] [Related]  

  • 3. The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin.
    Catanzaro A; Edgington TS
    J Lab Clin Med; 1974 Mar; 83(3):458-66. PubMed ID: 4272970
    [No Abstract]   [Full Text] [Related]  

  • 4. Digestion of fibrin by thrombin.
    Triantaphyllopoulos DC; Chandra S
    Biochim Biophys Acta; 1973 Nov; 328(1):229-32. PubMed ID: 4271567
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of a low molecular weight form of plasminogen.
    Paoni NF; Castellino FJ
    Biochem Biophys Res Commun; 1975 Jul; 65(2):757-64. PubMed ID: 125089
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinogen responses following thrombosis.
    Farrell GW
    Bibl Anat; 1973; 12():279-85. PubMed ID: 4790362
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.
    Unkeless J; Dano K; Kellerman GM; Reich E
    J Biol Chem; 1974 Jul; 249(13):4295-305. PubMed ID: 4368727
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of 125-I-fibrinogen and 131-I-albumin in experimental galactosamine hepatitis].
    von Mahn I; Merkel H; Sattler EL; Müller-Berghaus G
    Verh Dtsch Ges Inn Med; 1974; 80():437-9. PubMed ID: 4454578
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 10. Physicochemical and biological properties of human and canine plasmins.
    Takeda Y; Nakabayashi M
    J Clin Invest; 1974 Jan; 53(1):154-62. PubMed ID: 4128408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nuclear medical thrombosis diagnosis, current state and developmental trends].
    Endert G; Eger H; Kleinert P; Klose E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(2):157-62. PubMed ID: 50979
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of sialic acid in the determination of distinct properties of the isozymes of rabbit plasminogen.
    Siefring GE; Castellino FJ
    J Biol Chem; 1974 Dec; 249(24):7742-6. PubMed ID: 4430672
    [No Abstract]   [Full Text] [Related]  

  • 13. Incorporation of radiolabelled fibrinogen into venous thrombi induced in dogs.
    Kravis TC; Shibel EM; Brooks JD; Moser KM
    Circulation; 1974 Jan; 49(1):158-64. PubMed ID: 4808836
    [No Abstract]   [Full Text] [Related]  

  • 14. [Features of the interaction of Glu- and Lys-forms of plasminogen with native and partially hydrolyzed fibrin].
    Grinenko TV; Skomorovskaia EV; Kudinov SA; Zolotareva EN
    Biokhimiia; 1992 May; 57(5):728-37. PubMed ID: 1322196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The course and prerequisites of Lys-plasminogen formation during fibrinolysis.
    Suenson E; Thorsen S
    Biochemistry; 1988 Apr; 27(7):2435-43. PubMed ID: 3382632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein metabolism following injury.
    Davies JW
    J Clin Pathol Suppl (R Coll Pathol); 1970; 4():56-64. PubMed ID: 4123923
    [No Abstract]   [Full Text] [Related]  

  • 17. Cross-linking of salmon fibrinogen and fibrin by factor XIII and transglutaminase.
    Murtaugh PA; Halver JE; Gladner JA
    Biochem Biophys Res Commun; 1973 Oct; 54(3):849-55. PubMed ID: 4148128
    [No Abstract]   [Full Text] [Related]  

  • 18. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen turnover after massive haemorrhage in dogs studied with radioactively labelled fibrinogen.
    Leandoer L; Appelgren L; Bergentz SE
    Acta Chir Scand; 1968; 134(7):517-24. PubMed ID: 5731293
    [No Abstract]   [Full Text] [Related]  

  • 20. The short-term measurement of plasma protein catabolic rates.
    Zalin AM; Carson E; Black EG; Hoffenberg R
    J Nucl Biol Med; 1972; 16(2):73-80. PubMed ID: 4575657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.